View of Pembrolizumab as first line treatment of Merkel cell carcinoma patients – a case series of patients with various co-morbidities

Return to Article Details Pembrolizumab as first line treatment of Merkel cell carcinoma patients – a case series of patients with various co-morbidities Download Download PDF